Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06234488 · ClinicalTrials.gov registry record
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
A clinical trial of Breast Cancer and Breast Neoplasms, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- 125
- Enrollment target
- 20
- Study locations
NCT06234488 is a study of Breast Cancer and Breast Neoplasms that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 125 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT06234488, a study of Breast Cancer and Breast Neoplasms, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 20
- Study locations
Study Summary
There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.
Conditions Studied
Study Locations (20)
Illinois
- Northwestern Medicine - Chicago
- Rush University Medical Center - Chicago
- NorthShore University Health System - Evanston
Massachusetts
- Massachusetts General Hospital - Boston
- Birgham and Women's Hospital - Boston
- Boston University (Boston U) - Boston
California
- University of Southern California/Los Angeles (USC/LA County) - Los Angeles
- University of California San Francisco (UCSF) - San Francisco
Florida
- Mayo Clinic - Jacksonville
- Moffitt Cancer Center (MCC) - Tampa
New York
- New York University (NYU) - New York
- University of Rochester - Rochester
Colorado
- University of Colorado Anschutz Medical Campus (CU Anschutz) - Aurora
District of Columbia
- MedStar Georgetown University Hospital (MGUH) - Washington D.C.
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2023-12-08 |
| Est. Completion | 2026-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06234488
The ClinicalTrials.gov registry entry for NCT06234488 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06234488 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Illinois, Massachusetts, California.
Frequently Asked Questions
What is clinical trial NCT06234488 about?
NCT06234488 is a clinical study titled "Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study". There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD...
What is the current status of trial NCT06234488?
This trial is currently active not recruiting. The enrollment target is 125 participants. The study started on 2023-12-08. Estimated completion is 2026-08-30.
What conditions does trial NCT06234488 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasms, Breast Adenocarcinoma, Breast Cancer Stage IV, Breast Cancer Invasive.
Who is sponsoring clinical trial NCT06234488?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06234488 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.